Revvity Inc. (PKN)
XMUN 
Summary
PKN Chart
Revvity Q2: Headwinds From China And Customers, Buy On Weakness
Revvity, Inc.'s focus on high-growth markets like cell and gene therapies and precision medicine positions it for long-term expansion despite near-term challenges. The recent divestiture streamlines Revvity's portfolio, allowing greater investment in specialized diagnostics and software, which are expected to drive future growth. While facing weak academic/government demand and China headwinds, Revvity maintains a strong capital structure and margin expansion potential through cost optimization.
Revvity Stock Sinks on Lowered China Immunodiagnostics Outlook
Revvity (RVTY) was one of the worst-performing stocks in the S&P 500 Monday after the medical device maker said it anticipated a "meaningful pullback" in its immunodiagnostics business in China.
Top Stock Movers Now: Nike, Cheniere Energy, Revvity, and More
U.S. equities were mhigher at midday after President Donald Trump and European Commission President Ursula von der Leyen announced a new trade agreement between the U.S. and the European Union. The Dow Jones Industrial Average, Nasdaq, and S&P 500 all rose.
Revvity Inc. Dividends
| PKN 3 months ago | Other | €0.06 Per Share |
| PKN 6 months ago | Other | €0.06 Per Share |
| PKN 9 months ago | Other | €0.06 Per Share |
| PKN 19 Jul 2024 | Other | €0.06 Per Share |
| PKN 18 Apr 2024 | Other | €0.06 Per Share |
Revvity Inc. Earnings
| 28 Jul 2025 Date | | 1.14 Cons. EPS | - EPS |
| 28 Apr 2025 Date | | - Cons. EPS | - EPS |
| 30 Jan 2025 Date | | - Cons. EPS | - EPS |
| 28 Oct 2024 Date | | - Cons. EPS | - EPS |
| 30 Jul 2024 Date | | - Cons. EPS | - EPS |
| PKN 3 months ago | Other | €0.06 Per Share |
| PKN 6 months ago | Other | €0.06 Per Share |
| PKN 9 months ago | Other | €0.06 Per Share |
| PKN 19 Jul 2024 | Other | €0.06 Per Share |
| PKN 18 Apr 2024 | Other | €0.06 Per Share |
| 28 Jul 2025 Date | | 1.14 Cons. EPS | - EPS |
| 28 Apr 2025 Date | | - Cons. EPS | - EPS |
| 30 Jan 2025 Date | | - Cons. EPS | - EPS |
| 28 Oct 2024 Date | | - Cons. EPS | - EPS |
| 30 Jul 2024 Date | | - Cons. EPS | - EPS |
Revvity Inc. (PKN) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Revvity Inc. ever had a stock split?
Revvity Inc. Profile
| Medical - Diagnostics & Research Industry | Healthcare Sector | Prahlad R. Singh CEO | XMUN Exchange | US7140461093 ISIN |
| US Country | 11,000 Employees | 17 Oct 2025 Last Dividend | 4 Jun 2001 Last Split | - IPO Date |
Overview
Revvity, Inc., previously known as PerkinElmer, Inc., marks a significant name in the health sciences industry, offering comprehensive solutions, technologies, and services across the globe, including the Americas, Europe, Asia, and other international territories. With its inception in 1937 and headquarters in Waltham, Massachusetts, Revvity has grown to serve an expansive range of clients, including pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. Operating through two main segments - Life Sciences and Diagnostics - Revvity, Inc. brings forward a suite of instruments, reagents, informatics, software, and much more, catering to a wide array of testing, screening, and research needs in the health sciences sector.
Products and Services
Revvity, Inc.'s product portfolio and services are vast, covering various needs within the life sciences and diagnostics fields. Here's an overview of their most notable offerings:
- AutoDELFIA, BACS-on-Beads, BIOCHIPs, and similar products: These are used for the testing and screening of genetic abnormalities, disorders, and diseases. They serve a critical role in early detection and screening processes for conditions such as down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions.
- chemagic, Chitas, DELFIA, DELFIA Xpress, and related instruments: These instruments and technologies are essential for genomic workflows, supporting applications in oncology, immunodiagnostics, drug discovery, and more. They provide the necessary tools for researchers and healthcare practitioners to analyze and understand genetic material and protein interactions.
- JANUS, LabChip, LifeCycle, LimsLink, and similar software and systems: Key in informatics and laboratory management, these software solutions and systems optimize the operations within laboratories, improving efficiency, data management, and processing in research and diagnostic settings.
- Migele, MultiPROBE, NEXTFLEX, NextPrep, and other reagents and assay platforms: These products are designed for specific applications within the fields of diagnostics and life sciences research, including DNA sequencing, protein analysis, and more. They are integral to the processes of detecting, analyzing, and understanding complex biological materials.
- T-SPOT, Twister, VariSpec, ViaCord, VICTOR 2D, Zephyr, and more brand names: Under these brand names, Revvity, Inc. offers a diverse range of products that cater to different aspects of health sciences, from diagnostic tests for infectious diseases to advanced instruments for genetic and proteomic research. Each brand specializes in a unique area of the health sciences, providing specialized tools and technologies to their respective fields.
Contact Information
